Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Find various ways to generate immediate income and improve your financial situation. Start implementing these strategies now!
17,665 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Meta's AI forecast points to a near-term Bitcoin dip followed by a multi-week rally as ETF flows and policy catalysts...
When a major concert switches venues, fans face more than changed plans. Sting’s Tampa concert moves to Orlando, but ...
SpaceX priced its IPO terms at $135 per Class A share, issuing 555.6 million shares to raise about $75 billion and va...
Oil pushes above $116 per barrel as traders weigh supply disruptions and growing demand in 2026. The move highlights ...
Mackenzie Scott’s give-spree remains rapid and largely unrestricted, reshaping modern philanthropy. This article expl...
Cypherpunk Technologies reaffirms a 5% ZEC reserve despite a patched Zcash flaw, as investors debate the strategy ami...
A Georgia couple faced a frightening scam that claimed they missed federal jury duty. This article explains how fake ...
Bitcoin gave up weekend gains as oil surged and geopolitical tensions in the Middle East intensified, signaling renew...
NVIDIA CEO Jensen Huang positioned the latest AI stock pullback as a buying opportunity, a stance that reminds invest...
AI chip headlines are steering market moves this June. From Google’s foundry ambitions to Intel's refreshed strategy,...
Palantir emphasizes software-driven AI workflows with an asset-light model, while Oracle bets on cloud-scale GPU depl...